ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

Talbot, Schein Ask Weickar for 41.3 Billion for NCI

May 6, 1983

Course On Human Research Protections Goes Online @ Cancer.Gov.

January 26, 2001

In Brief: fraud By Trainee Leads Collins To Retract Five Paper; Weinstein Retires At Columbia

November 1, 1996

In Brief: Outstanding Investigator Awards Draw 150 Letters Of Intent; Applications Due July 15

June 15, 1984

NIH Study Sections Use New Scoring Procedure

July 3, 1998

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993